Categories for Uncategorized

7 Dec 2022 Leading UK Diagnostics Provider Source LDPath Expands AI Capabilities with Ibex Medical Analytics

Read more

4 Sep 2022 Ibex announces Galen™ 3.0, a transformative cancer diagnostics platform offering new detection capabilities and a broad feature set

Read more

2 Sep 2022 Ibex and Medipath Sign Multi-year, Multi-site and Multi-tissue Expansion of AI for Cancer Diagnosis Across France

Read more

1 Sep 2022 Excellent Outcomes for Galen Breast

Read more

15 Jun 2022 Ibex Obtains CE Mark for Galen Gastric, the World’s First AI-powered Solution for Gastric Cancer Detection

Read more

21 Mar 2022 Hartford HealthCare and Ibex Launch Research Initiative on AI-powered Solution to Improve Breast Cancer Diagnosis

Read more

10 Mar 2022 Dedalus and Ibex announce a strategic partnership to bring the power of artificial intelligence to digital pathology

Read more

24 Nov 2021 Ibex selected by India’s Dr. Lal PathLabs to Deliver AI-powered Cancer Diagnostics

Read more

3 Nov 2021 Ibex Selected by Kantonsspital Baselland to Deliver the First AI-powered Cancer Diagnostics Solution in Switzerland

Read more

18 Oct 2021 Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care

Read more

14 Sep 2021 Ibex Expands United States Operations: Appointing Douglas Clark MD, as Chief Medical Officer, Americas; CEO Relocating to Lead U.S. Headquarters

Read more

24 Aug 2021 Ibex Introduces Galen Gastric, World’s First AI-powered Solution for Gastrointestinal Cancer Diagnostics, at Maccabi Healthcare Services

Read more